Is it Finally Safe to Buy Teleflex Inc (NYSE:TFX)?

[Capital Cube] Teleflex Inc (NYSE:TFX)(TREND ANALYSISchange in share price of 15.95% for the last 12 months as well as its more recent 30-day share price performance of 3.99% are both in line with their respective peer medians. Thus, the company’s share performance over the last month and the last year has been firmly in the middle of the pack.

Stock Performance: Click here for a free comprehensive Trend Analysis Report

Teleflex Inc (NYSE:TFX) stock is currently trading 5.67% below its 52-week-high, 23.34% above its 52-week-low. The 1-year stock price history is in the range of $107.45 – $140.5. Teleflex Inc (TFX) has a price to earnings ratio of 33.2 versus Healthcare sector average of 54.85. TFX stock price has outperformed the S&P 500 by 13.3%. The Medical Products company is currently valued at $5.51 billion and its share price closed the last trading session at $132.53. The stock has a 50-day moving average of $129.29 and a 200-day moving average of $130.28.

Teleflex Inc (TFX) current short interest stands at 2.91 million shares. It has increased by 4% from the same period of last month. Around 8% of the company’s shares, which are float, are short sold. With a 10-days average volume of 0.21 million shares, the number of days required to cover the short positions stand at 14.2 days.

TFX reported last quarter earnings on October 29. The Medical Products company announced earnings per share of $1.6 against a consensus Street estimate of $1.56, beating the average estimate by $0.04. This corresponds to an increase of $0.22 compared to the same quarter of the previous fiscal year.

Is this a Buying Opportunity? Click here for a free Trend Analysis Report

There are currently twelve analysts that cover Teleflex Inc stock. Of those twelve, nine have a Buy rating, three have a Hold rating. On a consensus basis this yields to an Overweight rating. The consensus target price stands at $144.4.

A recent analyst activity consisted of Stephens & Co. upgrading their Equal-weight rating to Overweight on May 22. Stephens & Co. increased their price target on TFX from $126 to $147. This corresponds to a 10.92% upside from the last closing price. On the date of report, the stock closed at $129.39.

Barclays reiterated their Overweight stance on the same day, and increased their price target on TFX stock from $145 to $150. This corresponds to a 13.18% upside from the last closing price. On the date of report, the stock closed at $129.39.

Teleflex Inc (TFX) has a debt to equity ratio of 56% compared to Healthcare sector average of 70.3%. The company has a current ratio of 1.67. This ratio should be higher than one (ideally two) and is an indicator to show if the company is able to finance its short term obligations. Indeed it should have higher short term assets to dispose in order to cover for its short term liabilities.

Company snapshot

Teleflex Incorporated is a global provider of medical technology products. The Company primarily develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.

Related Posts

About The Author